| 发明名称 | HLA-G isoform for use in the treatment of a disease associated with bone resorption | ||
| 摘要 | Novel use of HLA-G isoforms in the treatment or prevention of diseases in which bone resorption is observed. | ||
| 申请公布号 | US9375464(B2) | 申请公布日期 | 2016.06.28 |
| 申请号 | US201113989303 | 申请日期 | 2011.11.23 |
| 申请人 | Etablissement Francais du Sang;Commissariat a l'Energie Atomique et aux Energies Alternatives | 发明人 | Deschaseaux Frédéric;Sensebe Luc;Rouas-Freiss Nathalie |
| 分类号 | A61K38/17;A61P19/08;A61K39/00 | 主分类号 | A61K38/17 |
| 代理机构 | Morgan, Lewis & Bockius LLP | 代理人 | Morgan, Lewis & Bockius LLP |
| 主权项 | 1. A method of treating bone resorption in a subject suffering from excess bone resorption, comprising administering to the subject a pharmaceutical composition comprising an isolated isoform of HLA-G selected from the group consisting of HLA-G1 and HLA-G5 and at least one pharmaceutically acceptable vehicle, wherein the isoform of HLA-G is in monomeric form. | ||
| 地址 | Saint Denis FR | ||